ENUMERIX
Live / Applied — First extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 06 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98536369
- Mark type
- Stylized text
- Filed
- 06 May 2024
- Published for opposition
- 24 Jun 2025
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 001 — Chemicals: Laboratory reagents for research purposes; enzyme and enzyme preparations for research purposes; polymerase chain reaction (PCR) reagents for research purposes; polymerase chain reaction (PCR) enzymes for research purposes; reverse transcriptions enzymes for research purposes; reagent polymerase chain reaction (PCR) master mixes, namely, pre-mixed reactants and reagents for research purposes; all the following sold individually or together as a kit, for quantitative polymerase chain reaction and quantitative reverse transcription polymerase chain reaction; scientific research kits comprising nucleotides for scientific and research use, diagnostic reagents, enzymes, agents in the nature of biochemical reagents used for non-medical purpose, assays for research purposes, buffer solutions for use in analytical chemistry and molecular biology, chemical preparations for scientific purposes used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, and biological preparations for use in science used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, all for use in scientific research other than for medical or veterinary use; chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations, except for medical and veterinary medical purposes; reagents and solvents for scientific and research use for the preparation of samples, the modification and manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; diagnostic components for molecular biology diagnostic scientific testing, namely, diagnostic reagents for scientific use
- Class 005 — Pharmaceuticals: Diagnostic components for molecular biology diagnostic testing, namely, diagnostic reagents for medicinal use
- Class 009 — Scientific and electric apparatus: Imaging apparatus and instruments, namely, non-medical imaging devices for the study of polymerase chain reaction (PCR) testing for scientific research purposes; downloadable software for facilitating and performing polymerase chain reaction (PCR) testing; laboratory equipment, namely, non-medical imaging devices using electronic detection for molecular diagnostics and molecular diagnostics analyzers; laboratory equipment, namely, non-medical imaging devices for use in the quantification of nucleic acids for use in research, translational, and clinical analysis; laboratory equipment, namely, non-medical imaging devices for use in the quality control of gene editing; laboratory equipment, namely, non-medical imaging devices for use in the detection, quantification, and monitoring of nucleic acids and molecular diagnostics.
- Class 042 — Scientific and technological services: Polymerase chain reaction (PCR) testing for scientific research purposes; scientific consulting and contract research services in the field of polymerase chain reaction (PCR) testing
Owner
- Enumerix, Inc., Palo Alto, CA, US
- Enumerix, Inc., Palo Alto, CA, US
Prosecution history
- 03 Feb 2026 — SOU EXTENSION 1 GRANTED
- 03 Feb 2026 — SOU EXTENSION 1 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Feb 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 Feb 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 19 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED